Skip to content
Dose Brief
Menu

Provider review

Longevity Meds review

By · Updated

A three-month commitment and conditional weight-loss guarantee sit behind low advertised starting rates. Read the cancellation policy alongside the homepage promise.

Not rated. This review examines published program information; it is not a firsthand treatment review.

At a glance

Semaglutide
From $144.99/month advertised; confirm the full required three-month charge
Tirzepatide
From $184.99/month advertised; confirm the full required three-month charge
Availability
Published state page excludes Louisiana weight-loss care and compounded weight-loss treatment in Mississippi; confirm individual eligibility.
Treatment formats
Compounded semaglutide and tirzepatide injections.

Payment policy requires three months and mentions an unspecified early-termination fee; homepage says cancellation is free.

In this review

Start with the commitment, not the headline

Longevity Meds advertises semaglutide from $144.99 a month and tirzepatide from $184.99, with no separate membership charge. Those are starting figures, not a verified personal quote. The payment policy requires a three-month weight-loss term and says the full supply is provided upfront. Confirm the total, formulation, quantity and payment schedule before treating either headline as a one-month purchase.

Cancellation promises do not agree

The homepage FAQ says a subscription can be canceled without charge. The separate payment policy says leaving the required term early incurs a termination fee, without stating its amount. Ending renewal, canceling an existing prescription and leaving a payment commitment are different actions; our GLP-1 cancellation and refund guide explains the questions to separate. Request written clarification of all three before entering payment details.

What the 90-day guarantee actually requires

The guarantee applies to an eligible patient who completes 90 consecutive treatment days with no net weight reduction. Its detailed policy requires adherence, requested check-ins and verifiable starting, interim and final weight records. A claim must be submitted within 30 days after the period. It also excludes some situations where continuing treatment becomes medically inappropriate, subject to applicable law. This is a conditional refund policy, not a promise of a particular result.

Named partners and state restrictions

The current partner page names MD Integrations for clinical services and The Pharmacy Hub and Greenwich RX as pharmacy partners, with contact information. These disclosures help identify questions to ask, but do not establish the clinician or pharmacy assigned to you. Use our compounding pharmacy verification checklist when you receive the pharmacy name. The state page separately says MDI does not offer obesity care in Louisiana and supports only branded weight-loss medication in Mississippi. A broad clinician-coverage statement is not universal access to the advertised compounds.

Refund cutoff and extra charges

The payment policy allows a pre-consultation cancellation request subject to approval and says a declined prescription receives a full refund. Once a consultation is complete and an approved prescription is sent to the pharmacy, it treats the order as final. A requested medication change after transmission carries a stated $150 reprocessing fee and still needs clinical approval. These are provider terms, not a determination of your legal refund rights.

Who should compare it?

The named care partners and detailed guarantee give readers more to investigate than an isolated price. The unresolved cancellation fee and mandatory term make this a poor choice for anyone relying on a free one-month trial. Before committing, obtain a single written order summary that reconciles the offer, minimum obligation, guarantee eligibility and pharmacy assignment.

What stands out

  • Names clinical and pharmacy partners
  • Publishes detailed guarantee requirements
  • Lists product-specific state restrictions

What to check

  • Starting rates do not establish the complete commitment
  • Cancellation claims conflict across pages
  • Early-termination fee amount is unspecified

Sources and review scope

Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.